Evidence map›Paper›PMID 26154564›Full record

ArticleClinical and experimental immunology2015

Collectin liver 1 and collectin kidney 1 and other complement-associated pattern recognition molecules in systemic lupus erythematosus.

A Troldborg, S Thiel, L Jensen, S Hansen, M J Laska, B Deleuran, J C Jensenius, K Stengaard-Pedersen

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Advances in the lectin pathway in systemic lupus erythematosus: from clinical correlations and mechanisms to targeted interventions.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Decreased expression ofCancer management and research · 2018
    Article
  16. Lectin complement pathway proteins in healthy individuals.Clinical and experimental immunology · 2017
    Article
  17. Article
  18. Serum proteomics study reveals candidate biomarkers for systemic lupus erythematosus.International journal of clinical and experimental pathology · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

A TroldborgCenter of Cancer and Inflammation, Department of Rheumatology, Aarhus University Hospital, Aarhus University.
S ThielDepartment of Biomedicine, Aarhus University.
L JensenDepartment of Biomedicine, Aarhus University.
S HansenDepartment of Cancer and Inflammation Research, University of Southern Denmark.
M J LaskaDepartment of Biomedicine, Aarhus University.
B DeleuranCenter of Cancer and Inflammation, Department of Rheumatology, Aarhus University Hospital, Aarhus University.
J C JenseniusDepartment of Biomedicine, Aarhus University.
K Stengaard-PedersenCenter of Cancer and Inflammation, Department of Rheumatology, Aarhus University Hospital, Aarhus University.
Aarhus University · DKAarhus University Hospital · DKUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to explore the involvement of collectin liver 1 (CL-L1) and collectin kidney 1 (CL-K1) and other pattern recognition molecules (PRMs) of the lectin pathway of the complement system in a cross-sectional cohort of systemic lupus erythematosus (SLE) patients. Concentrations in plasma of CL-L1, CL-K1, mannan-binding lectin (MBL), M-ficolin, H-ficolin and L-ficolin were determined in 58 patients with SLE and 65 healthy controls using time-resolved immunoflourometric assays. The SLE patients' demographic, diagnostic, clinical and biochemical data and collection of plasma samples were performed prospectively during 4 months. CL-L1, CL-K1 and M-ficolin plasma concentrations were lower in SLE patients than healthy controls (P-values < 0.001, 0.033 and < 0.001, respectively). H-ficolin concentration was higher in SLE patients (P < 0.0001). CL-L1 and CL-K1 plasma concentrations in the individuals correlated in both patients and controls. Patients with low complement component 3 (C3) demonstrated a negative correlation between C3 and CL-L1 and CL-K1 (P = 0.022 and 0.031, respectively). Patients positive for anti-dsDNA antibodies had lower levels of MBL in plasma than patients negative for anti-dsDNA antibodies (P = 0.02). In a cross-sectional cohort of SLE patients, we found differences in the plasma concentrations of CL-L1, CL-K1, M-ficolin and H-ficolin compared to a group of healthy controls. Alterations in plasma concentrations of the PRMs of the lectin pathway in SLE patients and associations to key elements of the disease support the hypothesis that the lectin pathway plays a role in the pathogenesis of SLE.

Indexed as

AdolescentAdultCohort StudiesCollectinsComplement Pathway, Mannose-Binding LectinCross-Sectional StudiesEnzyme-Linked Immunosorbent AssayFemaleFicolinsFluoroimmunoassayGlycoproteinsHumansLectinsLupus Erythematosus, SystemicMannose-Binding LectinMiddle AgedCOLEC10 protein, humanColec11 protein, humanCollectinsFCN3 protein, humanFicolinsGlycoproteinsLectinsMannose-Binding Lectincomplement systemlectin pathwaypattern recognition moleculessystemic lupus erythematosus

Identifiers

PMID26154564
PMCPMC4608502
OpenAlexW2130420735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.